Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 46


Mecp2-null mice provide new neuronal targets for Rett syndrome.

Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez AF, Esteller M.

PLoS One. 2008;3(11):e3669. doi: 10.1371/journal.pone.0003669. Epub 2008 Nov 7.


Deletion of Mecp2 in Sim1-expressing neurons reveals a critical role for MeCP2 in feeding behavior, aggression, and the response to stress.

Fyffe SL, Neul JL, Samaco RC, Chao HT, Ben-Shachar S, Moretti P, McGill BE, Goulding EH, Sullivan E, Tecott LH, Zoghbi HY.

Neuron. 2008 Sep 25;59(6):947-58. doi: 10.1016/j.neuron.2008.07.030.


MeCP2, a key contributor to neurological disease, activates and represses transcription.

Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY.

Science. 2008 May 30;320(5880):1224-9. doi: 10.1126/science.1153252.


Specific mutations in methyl-CpG-binding protein 2 confer different severity in Rett syndrome.

Neul JL, Fang P, Barrish J, Lane J, Caeg EB, Smith EO, Zoghbi H, Percy A, Glaze DG.

Neurology. 2008 Apr 15;70(16):1313-21. doi: 10.1212/01.wnl.0000291011.54508.aa. Epub 2008 Mar 12.


Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome.

Belichenko NP, Belichenko PV, Li HH, Mobley WC, Francke U.

J Comp Neurol. 2008 May 1;508(1):184-95. doi: 10.1002/cne.21673.


Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes.

Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM.

Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19416-21. Epub 2007 Nov 27.


GPR26: a marker for primary glioblastoma?

Carter AN, Cole CL, Playle AG, Ramsay EJ, Shervington AA.

Mol Cell Probes. 2008 Apr;22(2):133-7. Epub 2007 Oct 26.


The story of Rett syndrome: from clinic to neurobiology.

Chahrour M, Zoghbi HY.

Neuron. 2007 Nov 8;56(3):422-37. Review.


Tissue distribution and functional analyses of the constitutively active orphan G protein coupled receptors, GPR26 and GPR78.

Jones PG, Nawoschik SP, Sreekumar K, Uveges AJ, Tseng E, Zhang L, Johnson J, He L, Paulsen JE, Bates B, Pausch MH.

Biochim Biophys Acta. 2007 Jun;1770(6):890-901. Epub 2007 Feb 3.


Mutations in autism susceptibility candidate 2 (AUTS2) in patients with mental retardation.

Kalscheuer VM, FitzPatrick D, Tommerup N, Bugge M, Niebuhr E, Neumann LM, Tzschach A, Shoichet SA, Menzel C, Erdogan F, Arkesteijn G, Ropers HH, Ullmann R.

Hum Genet. 2007 May;121(3-4):501-9. Epub 2007 Jan 9.


Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males.

del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, Berry SA, Pursley AA, Grebe TA, Freedenberg D, Martin RA, Hsich GE, Khera JR, Friedman NR, Zoghbi HY, Eng CM, Lupski JR, Beaudet AL, Cheung SW, Roa BB.

Genet Med. 2006 Dec;8(12):784-92.


Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.

McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY.

Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18267-72. Epub 2006 Nov 15.


Recurrent infections, hypotonia, and mental retardation caused by duplication of MECP2 and adjacent region in Xq28.

Friez MJ, Jones JR, Clarkson K, Lubs H, Abuelo D, Bier JA, Pai S, Simensen R, Williams C, Giampietro PF, Schwartz CE, Stevenson RE.

Pediatrics. 2006 Dec;118(6):e1687-95. Epub 2006 Nov 6.


Expression profiling of clonal lymphocyte cell cultures from Rett syndrome patients.

Delgado IJ, Kim DS, Thatcher KN, LaSalle JM, Van den Veyver IB.

BMC Med Genet. 2006 Jul 21;7:61.


Early progressive encephalopathy in boys and MECP2 mutations.

Kankirawatana P, Leonard H, Ellaway C, Scurlock J, Mansour A, Makris CM, Dure LS 4th, Friez M, Lane J, Kiraly-Borri C, Fabian V, Davis M, Jackson J, Christodoulou J, Kaufmann WE, Ravine D, Percy AK.

Neurology. 2006 Jul 11;67(1):164-6.


Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome.

Kriaucionis S, Paterson A, Curtis J, Guy J, Macleod N, Bird A.

Mol Cell Biol. 2006 Jul;26(13):5033-42.


Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.

Peddada S, Yasui DH, LaSalle JM.

Hum Mol Genet. 2006 Jun 15;15(12):2003-14. Epub 2006 May 8.


The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.

Chang Q, Khare G, Dani V, Nelson S, Jaenisch R.

Neuron. 2006 Feb 2;49(3):341-8.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk